14 / 99
L
ima
FMT
de
et
al
.
394
R
ev
A
ssoc
M
ed
B
ras
2016; 62(5):389-394
recommendations were formulated for each outcome,
and the best type of treatment for each type of manifes-
tation should be chosen at the discretion of the attend-
ing physician.
R
eferences
1.
Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, et
al. A randomized trial of surgery in the treatment of single metastases to
the brain. N Engl J Med. 1990; 322(8):494-500.
2. Vecht CJ, Haaxma-Reiche H, Noordijk EM, Padberg GW, Voormolen JH,
Hoekstra FH, et al. Treatment of single brain metastasis: radiotherapy alone
or combined with neurosurgery? Ann Neurol. 1993; 33(6):583-90.
3.
Mintz AH, Kestle J, Rathbone MP, Gaspar L, Hugenholtz H, Fisher B, et al.
A randomized trial to assess the efficacy of surgery in addition to radiotherapy
in patients with a single cerebral metastasis. Cancer. 1996; 78(7):1470-6.
4.
Pamar MKB, Torri V, Stewart L. Extracting summary statistics to perform
meta-analysis of the published literature for survival endpoints. Stat Med.
1998; 17(24):2815-34,.
5. Williamson PR, Smith CT, Hutton JL, Marson AG. Aggregate data meta-
analysis with time-to-event outcomes. Stat Med. 2002; 21(22):3337-51.
6.
Hart MG, Grant R, Walker M, Dickinson H. Surgical resection and whole
brain radiation therapy versus whole brain radiation therapy alone for single
brain metastases. Cochrane Database Syst Rev. 2005; (1):CD003292.
7. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell
MC, et al. Whole brain radiation therapy with or without stereotactic
radiosurgery boost for patients with one to three brain metastases: phase
III results of the RTOG 9508 randomised trial. Lancet. 2004;
363(9422):1665-72.
8.
Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic
radiosurgery plus whole brain radiotherapy versus radiotherapy alone for
patients with multiple brain metastases. Int J Radiat Oncol Biol Phys. 1999;
45(2):427-34.
9. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, et al.
Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic
radiosurgery alone for treatment of brain metastases: a randomized controlled
trial. JAMA. 2006; 295(21):2483-91.
10. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, et al.
Neurocognition in patients with brain metastases treated with radiosurgery
or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
Lancet Oncol. 2009; 10(11):1037-44.
11.
Kocher M, Soffietti R, Abacioglu U, Villà S, Fauchon F, Baumert BG, et al.
Adjuvant whole-brain radiotherapy versus observation after radiosurgery
or surgical resection of one to three cerebral metastases: results of the EORTC
22952-26001 study. J Clin Oncol. 2011; 29(2):134-41.
12.
Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG, et
al. A European Organization for Research and Treatment of Cancer phase
III trial of adjuvant whole-brain radiotherapy versus observation in
patients with one to three brain metastases from solid tumors after
surgical resection or radiosurgery: quality-of-life results. J Clin Oncol.
2013; 31(1):65-72.
13. Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, Hirota S, et al.
Neurocognitive function of patients with brain metastasis who received
either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery
alone. Int J Radiat Oncol Biol Phy.s 2007; 68(5):1388-95.